Biogen Inc.
$BIIB
Public valuation for Biogen Inc. (BIIB). Fair value, signal, and key metrics — no sign-in required.
Current Price
$202.95
37% Overvalued
Fair Value Estimate
$127
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $233.87
15% higher than current
Key Metrics
Market Cap
$30.0B
Forward P/E
17.2x
Operating Margin
16.0%
Revenue Growth
-0.8%
PEG Ratio
10.99
Get free watchlist alerts
Join the waitlist for valuation updates on $BIIB and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.